Literature DB >> 12714471

Erythromelalgia induced by possible calcium channel blockade by ciclosporin.

Gurvinder P Thami1, Mala Bhalla.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12714471      PMCID： PMC153834          DOI： 10.1136/bmj.326.7395.910

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  Cyclosporin enhances the tendency towards oedema and flushing noted on dihydropyridine calcium channel blockers.

Authors:  R O von Vigier; E Fossali; A Edefonti; B Vogt; M G Bianchetti
Journal:  Br J Clin Pharmacol       Date:  2002-09       Impact factor: 4.335

2.  Erythromelalgia induced by nicardipine (inverse Raynaud's phenomenon?).

Authors:  H Levesque; N Moore; L M Wolfe; H Courtois
Journal:  BMJ       Date:  1989-05-06

Review 3.  Cyclosporine. An immunosuppressant affecting epithelial cell proliferation.

Authors:  J Kanitakis; J Thivolet
Journal:  Arch Dermatol       Date:  1990-03

4.  Leg bone pain syndrome due to cyclosporine in a renal transplant patient.

Authors:  E Naredo Sánchez; A Balsa Criado; A Sanz Guajardo; L Pantoja Zarza; E Martín Mola; J Gijón Baños
Journal:  Clin Exp Rheumatol       Date:  1994 Nov-Dec       Impact factor: 4.473

5.  Cyclosporin A binding to calmodulin: a possible site of action on T lymphocytes.

Authors:  P M Colombani; A Robb; A D Hess
Journal:  Science       Date:  1985-04-19       Impact factor: 47.728
  5 in total
  3 in total

1.  [Erythromelalgia: skin redness and pain].

Authors:  M Dusch; M Schmelz
Journal:  Schmerz       Date:  2019-10       Impact factor: 1.107

2.  Leg bone pain syndrome in a patient with ulcerative colitis treated with cyclosporin.

Authors:  A H Abdul Rahman; C O'Brien; S E Patchett
Journal:  Ir J Med Sci       Date:  2007-04-13       Impact factor: 1.568

Review 3.  Current pain management strategies for patients with erythromelalgia: a critical review.

Authors:  See Wan Tham; Marian Giles
Journal:  J Pain Res       Date:  2018-08-30       Impact factor: 3.133
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.